PAPER Abramsson A, Kettunen P, Banote RK, Lott E, Li M, Arner A, Zetterberg H
SEARCH RESULTS
329930 RESULTS
PAPER Itokazu Y, Kato-Negishi M, Nakatani Y, Ariga T, Yu RK
Effects of Amyloid β-Peptides and Gangliosides on Mouse Neural Stem Cells.
Neurochem Res. 2013 Oct;38(10):2019-27. PubMed: 23851714PAPER Schnaars M, Beckert H, Halle A
Assessing β-amyloid-induced NLRP3 inflammasome activation in primary microglia.
Methods Mol Biol. 2013;1040:1-8. PubMed: 23852592PAPER Cui J, Jothishankar B, He P, Staufenbiel M, Shen Y, Li R
Amyloid Precursor Protein Mutation Disrupts Reproductive Experience-Enhanced Normal Cognitive Development in a Mouse Model of Alzheimer's Disease.
Mol Neurobiol. 2013 Jul 14; PubMed: 23853041PAPER Wang C, Yu JT, Miao D, Wu ZC, Tan MS, Tan L
Targeting the mTOR Signaling Network for Alzheimer's Disease Therapy.
Mol Neurobiol. 2013 Jul 14; PubMed: 23853042PAPER Burnes DP, Burnette D
Broadening the etiological discourse on Alzheimer's disease to include trauma and posttraumatic stress disorder as psychosocial risk factors.
J Aging Stud. 2013 Aug;27(3):218-24. PubMed: 23849419PAPER Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE
Evidence for impaired amyloid β clearance in Alzheimer's disease.
Alzheimers Res Ther. 2013 Jul 12;5(4):33. PubMed: 23849219PAPER Zilkens RR, Duke J, Horner B, Semmens JB, Bruce DG
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849590PAPER Verlinden VJ, van der Geest JN, Hofman A, Ikram MA
Cognition and gait show a distinct pattern of association in the general population.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849591PAPER Solomon A, Ngandu T, Soininen H, Hallikainen MM, Kivipelto M, Laatikainen T
Validity of dementia and Alzheimer disease diagnoses in Finnish national registers.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849592PAPER Blom K, Emmelot-Vonk MH, Koek HL
The influence of vascular risk factors on cognitive decline in patients with dementia: A systematic review.
Maturitas. 2013 Oct;76(2):113-7. PubMed: 23849703PAPER Zhang J, Cao Q, Li S, Lu X, Zhao Y, Guan JS, Chen JC, Wu Q, Chen GQ
3-hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism.
Biomaterials. 2013 Oct;34(30):7552-62. PubMed: 23849878PAPER Phillips NR, Simpkins JW, Roby RK
Mitochondrial DNA deletions in Alzheimer's brains: A review.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850329PAPER Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H
CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850330PAPER Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, Galasko D
Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: Beyond cognition.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850331Current Filters
No filters selected